VIRAX BIOLABS GROUP LTD

VRAXNASDAQ

🏆 #5230 by market capUS Equity

——

Quote unavailable

24h—

7d—

14d—

30d—

ytd—

1y—

🏦Market Cap

$2M

Small Cap

📈Revenue Growth (YoY)

96.2%

High Growth

📊Gross Margin

-1480.5%

Thin

💵FCF Margin

-56607.7%

Thin

⚖️P/S Ratio

115.0x

Expensive

Otter Score

—

Insufficient data

🔭

No analyst ratings for VRAX

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.